Table 2 Daily Dose (mg/day) of Index Atypical Antipsychotic: During the 1-Year Post Initiation, at Initiation, and at Endpoint
Group/Time | Mean (SD) | Median | Min/Max | Mean Mono/Poly* |
|---|---|---|---|---|
Olanzapine | ||||
1-Year | 13.9 (7.4) | 10.0 | 2.5/40 | 15.1/13.5 |
Initiation | 10.0 (6.1) | 10.0 | 2.5 / 40 | 10.7 / 9.5 |
Endpoint | 14.2 (8.4) | 10.0 | 2.5 / 50 | 13.9 / 14.5 |
Quetiapine | ||||
1-Year | 330 (214) | 295 | 25/850 | 305/334 |
Initiation | 164.2 (151) | 100 | 12.5 / 800 | 223 / 138 |
Endpoint | 341 (277) | 300 | 25 / 1300 | 369 / 330 |
Risperidone | ||||
1-Year | 4.2 (2.3) | 3.9 | 0.28/12.9 | 4.7/3.9 |
Initiation | 2.7 (2.0) | 2.0 | 0.25 / 12 | 3.2 / 2.4 |
Endpoint | 4.3 (2.7) | 4.0 | 0.25 / 16 | 4.5 / 4.1 |